GMP Plasmid Manufacturing Services
Integrated Plasmid Production to Streamline and Accelerate Viral Vector Manufacturing
With over 20 years of experience in cell and gene therapy manufacturing, Andelyn understands how plasmid DNA manufacturing impacts viral vector packaging performance. Our integrated plasmid manufacturing approach creates a seamless transition from plasmid production through vector development to GMP manufacturing with dedicated program management throughout.
Under one MSA, our integrated approach streamlines the path from plasmid production through vector development to commercial manufacturing, with integrated program management for both plasmid and vector programs provided by an experienced plasmid manufacturer and plasmid company.
A Commitment to Quality at Every Stage of Your Program
Andelyn offers a spectrum of plasmid DNA grades tailored to support your project at every stage. Our unique approach to quality control is built on a single-use mindset, and we manufacture all GMP plasmid DNA products in a cleanroom environment.
We prioritize high-quality plasmid DNA to ensure consistency and compliance with clinical development and GMP manufacturing standards.
As one of the experienced plasmid manufacturing companies, we provide traceability from raw materials through release, aligning with regulatory expectations for DNA plasmid manufacturing and consistent plasmid production services.
| Research | Tox | GMP | |
|---|---|---|---|
| Applications | In vitro R&D, PC studies | Toxicology studies | Clinical, Commercial |
| Scale | Flask | Flask / 50L Fermenter | Flask / 50L Fermenter |
| Testing Panel | Reduced | Extended | Extended |
| Cloning | |||
| Yield Assessment / DOE | |||
| CoA | |||
| E. coli MCB Production | |||
| Plasmid Stability (Upon Request) | |||
| Single-use disposable | |||
| TSE/BSE statement | |||
| Manufactured in clean room | |||
| QA oversight |
Customized Testing Strategy to Meet Specific Program Requirements
| Source | Research | Tox | GMP | |
|---|---|---|---|---|
| DNA Homogeneity | In-house | |||
| Identity | In-house | |||
| Purity | In-house | |||
| Restriction Digest | In-house | |||
| Concentration | In-house | |||
| Identity (DNA) | In-house / NCH IGM | |||
| Endotoxin | In-house | |||
| Residual Host Protein | In-house | |||
| Residual Host Genomic DNA | In-house | |||
| Residual Host RNA | In-house | |||
| pH | In-house | |||
| Mycoplasma | In-house |
Andelyn Development Center
Explore the Andelyn Development Center (ADC), where precision-based process development, preclinical manufacturing, and analytical capabilities converge for plasmids and viral vectors. As the cornerstone of our experience in gene and cell therapy, the ADC supports plasmid manufacturing, plasmid production service optimization, and analytical method development, ensuring fit-for-purpose solutions from early discovery to IND-enabling studies.
Andelyn Commercial Center
Step inside the Andelyn Commercial Center (ACC), our clinical and commercial production facility built for the rigors of cell and gene therapy manufacturing. With advanced cleanroom technologies and GMP-compliant design and operations, the ACC produces GMP and commercial-grade, high-quality plasmids and viral vectors. This facility anchors our plasmid suppliers capabilities and enables our plasmid CDMO to reliably advance programs to market while maintaining robust controls required for GMP plasmid DNA and compliant plasmid manufacturing.
In-House Plasmid Production Means Secure Supply Chains
Working closely with a CDMO that performs in-house plasmid production affords companies the opportunity to collaborate, optimize processes, and create efficiencies.
As a full-service plasmid manufacturer and plasmid DNA manufacturer, we provide continuity and risk mitigation by integrating plasmid manufacturing with downstream workflows.
Frequently Asked Questions
What is plasmid manufacturing?
Plasmid manufacturing is the end-to-end process of producing high-quality plasmid DNA for research, preclinical, clinical, and commercial use. As a plasmid manufacturer and plasmid CDMO, Andelyn provides plasmid production services that encompass strain and construct selection, upstream fermentation, downstream purification, comprehensive analytics, and release. As an experienced plasmid supplier and trusted plasmid manufacturing company, we ensure that plasmid DNA manufacturing consistently yields robust, reproducible material that meets regulatory and performance requirements, including GMP plasmids and GMP plasmid DNA for vector production and other applications.
How are plasmids produced at scale?
At scale, we produce plasmids in engineered bacterial hosts through controlled fermentation. Our plasmid production service uses scalable single-use bioreactors, optimized media, and tightly controlled growth conditions to maximize yield and quality. The process begins with GMP bacterial cell banking, followed by seed train expansion and high-density fermentation. After fermentation, we harvest and lyse cells to release plasmid DNA, which then undergoes downstream purification and quality control testing. As a leading plasmid DNA manufacturer, we leverage platform processes to ensure consistent outcomes from pilot to commercial runs. This approach ensures our GMP plasmids meet stringent specifications and keeps our plasmid production services reliable for clients who need repeatable performance.
What are the main steps in plasmid production?
The main steps in plasmid manufacturing include:
- construct and strain selection;
- GMP cell bank creation and qualification;
- upstream fermentation to amplify plasmid DNA;
- cell harvest and lysis;
- downstream purification tailored to plasmid DNA;
- formulation and sterile filtration; and
- release testing and stability.
Our plasmid manufacturing company coordinates each stage within a single program plan, enabling a seamless handoff from plasmid DNA manufacturing to vector development. Throughout, our in-house plasmid QC validates identity, purity, supercoiled content, endotoxin, and residuals, ensuring that plasmid manufacturing output aligns with the needs of viral vector platforms and GMP plasmid DNA requirements.
What purification methods are used for plasmid DNA?
Plasmid DNA purification includes alkaline lysis, followed by clarification and multimodal polishing. As a seasoned plasmid manufacturer, we deploy a toolbox of chromatographic and filtration techniques. These can include tangential flow filtration for concentration and buffer exchange, anion-exchange chromatography for capture, hydrophobic interaction resins for impurity removal, and final sterile filtration. Our plasmid production service uses scalable, single-use systems to minimize cross-contamination risk. For GMP plasmids, we emphasize validated steps that remove genomic DNA, host cell proteins, RNA, endotoxin, and process residuals, ensuring the final product meets regulatory expectations.
How long does plasmid manufacturing take?
Typical plasmid manufacturing timelines vary by scale, complexity, and testing requirements. For research-grade lots, production may be completed in 6–10 weeks. Typically, if you're doing a cell bank before production, it's about 16 weeks for the MCB and then another 5 months for plasmid production. As a responsive plasmid DNA manufacturer, we align schedules through integrated program management, reducing handoffs and compressing critical path activities. Our plasmid company leverages platform processes and in-house analytics to shorten cycle times while maintaining the rigor expected of leading plasmid DNA manufacturers. Early engagement with our plasmid manufacturing company enables accurate forecasting and on-time delivery.